HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Design, synthesis, and biological evaluation of novel γ-carboline ketones as anticancer agents.

Abstract
A series of novel γ-carboline ketones were designed, synthesized and evaluated for their cytotoxic activity in vitro against six human cancer cell lines (A549, SGC, HCT116, MCF-7, K562 and K562R). Biological evaluation revealed that almost all of the new compounds displayed moderate to potent cytotoxic activities against the tested cells. Among them, seven of the fourteen new compounds show more potent cytotoxic activities against K562R cell line than that of the positive control, taxol. Primary mechanism research on the most potent compound 6f indicated that it was a potent tubulin polymerization inhibitor, with IC(50) value of 4.3 μM, equivalent to that of CA-4, and arresting cell cycle in G(2)/M phase.
AuthorsJing Chen, Tao Liu, Rui Wu, Jianshu Lou, Xiaowu Dong, Qiaojun He, Bo Yang, Yongzhou Hu
JournalEuropean journal of medicinal chemistry (Eur J Med Chem) Vol. 46 Issue 4 Pg. 1343-7 (Apr 2011) ISSN: 1768-3254 [Electronic] France
PMID21342735 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Ketones
  • Tubulin
Topics
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Cell Line, Tumor
  • Drug Design
  • Humans
  • Ketones (chemical synthesis, chemistry, pharmacology)
  • Protein Multimerization (drug effects)
  • Protein Structure, Quaternary
  • Structure-Activity Relationship
  • Tubulin (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: